Floatz logo

MIDAZOLAM

Procedural Sedation

University of Sao PauloSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Procedural Sedation cohort.

Asset / SponsorPhaseRating
CLORAL HYDRATE
University of Sao Paulo
Phase 2CC
Desflurane
University Hospital, Clermont-Ferrand
N/AD
RAMIFENTANYL
University Hospital, Clermont-Ferrand
N/AD
SUFENTANIL CITRATE
University Hospital, Clermont-Ferrand
N/AD
PROPOFOL
University Hospital, Clermont-Ferrand
N/AD
CISATRACURIUM ION
University Hospital, Clermont-Ferrand
N/AD

Same molecule, other indications

MIDAZOLAM is also rated in:

gastrointestinal stromal tumorDormant
BBB
Indicative ·
75 / 100
View asset →
neuralgiaDormant
BBB
Indicative ·
75 / 100
View asset →
epilepsyDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →